Cargando…
Will a mAb-Based Immunotherapy Directed against Cancer Stem Cells Be Feasible?
The cancer stem cell (CSC) hypothesis suggests that within a tumor, there is a small subpopulation of cells with stem cell properties responsible for tumor maintenance and metastasis generation. This hypothesis also implies that new antitumor drugs, rather than targeting the bulk of the tumor mass,...
Autores principales: | Santamaria, Silvia, Delgado, Marisa, Kremer, Leonor, Garcia-Sanz, Jose A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684111/ https://www.ncbi.nlm.nih.gov/pubmed/29170667 http://dx.doi.org/10.3389/fimmu.2017.01509 |
Ejemplares similares
-
Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9(+) tumors
por: Santamaria, Silvia, et al.
Publicado: (2022) -
SEPPA-mAb: spatial epitope prediction of protein antigens for mAbs
por: Qiu, Tianyi, et al.
Publicado: (2023) -
Mechanisms of action of monoclonal antibodies in oncology integrated in IMGT/mAb-DB
por: Manso, Taciana, et al.
Publicado: (2023) -
IL36 Cooperates With Anti-CTLA-4 mAbs to Facilitate Antitumor Immune Responses
por: Qu, Qiuxia, et al.
Publicado: (2020) -
Subunit selectivity and epitope characterization of mAbs directed against the GABAA/benzodiazepine receptor
Publicado: (1990)